LN Met 25 Tablet ER
Marketer
Eris Lifesciences Ltd
Salt Composition
Cilnidipine (10mg) + Metoprolol Succinate (25mg)
Overview LN Met 25 Tablet ER
LN Met 25 ER tablets manage hypertension (high blood pressure). This dual-medication formulation effectively controls blood pressure when monotherapy proves insufficient. Lowering blood pressure helps prevent future strokes and heart attacks. LN Met 25 ER can be taken with food at any time, ideally consistently daily. Continue treatment as prescribed; high blood pressure often lacks symptoms, so self-discontinuation is risky and may worsen your condition. Lifestyle changes, including regular exercise, weight management, and a healthy diet, complement this medication. Always follow your physician's instructions. Potential side effects include headache, ankle edema, bradycardia, and nausea. Dizziness is possible; avoid driving or tasks requiring alertness until the effects are known. Elevate your legs to minimize swelling. Regular monitoring of blood pressure, kidney function, blood glucose, and electrolytes is common. Inform your doctor about pre-existing liver or kidney conditions, or pregnancy/breastfeeding before commencing treatment. Disclose all other medications, particularly those for hypertension or heart problems.
Uses of LN Met 25 Tablet ER
Elevated arterial blood pressure
Major Benefits of LN Met 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the LN Met 25 Tablet ER whole; avoid chewing, crushing, or breaking it. It should be taken with food.
Common Side effects of LN Met 25 Tablet ER:
- Abnormal phosphorous level in blood
- Hypotension (low blood pressure)
- Skin rash
How to use LN Met 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. LN Met 25 Extended-Release Tablet should be administered with a meal.
How LN Met 25 Tablet ER works:
Extended-release Metformin and Linagliptin 25 mg tablets combine two distinct medications.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and LN Met 25 Tablet ER is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release metformin 25 mg tablets (LN Met 25) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of LN Met 25 Tablet ER with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release metformin 25 mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data on the use of LN Met 25 Tablet ER in individuals with impaired renal function is scarce. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using extended-release LN Met 25 mg tablets. Dosage modification of LN Met 25 mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take LN Met 25 Tablet ER :
Should you forget to take a dose of your LN Met 25 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About LN Met 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |






